SCHEMBL8560841

SCHEMBL8560841

CSc1nc(I)cc(I)n1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.36
HSP90AB1 P08238 2/20 0.36
ALDH1A1 P00352 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KMT2A Q03164 5/20 0.33
MEN1 O00255 3/20 0.33
KDM4E B2RXH2 3/20 0.33
HTT P42858 2/20 0.33
THRB P10828 1/20 0.33
MAPK1 P28482 1/20 0.33
MAPT P10636 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
POLB P06746 3/20 0.32
GAA P10253 2/20 0.32
HSP90AA1 P07900 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
LMNA P02545 1/20 0.31
APOBEC3G Q9HC16 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12871725 0.85 POLB (0.46) PKMHSP90AB1ALDH1A1KMT2AMEN1
SCHEMBL12105468 0.84 POLB (0.46) PKMHSP90AB1KMT2AMEN1KDM4E
SCHEMBL1445103 0.76 MAPT (0.51) PKMHSP90AB1ALDH1A1L3MBTL1KMT2A
SCHEMBL7537282 0.71 HSP90AB1 (0.48) PKMHSP90AB1ALDH1A1L3MBTL1KMT2A
SCHEMBL164463 0.70
SCHEMBL13851785 0.70
SCHEMBL1885381 0.69 POLB (0.65) PKMHSP90AB1ALDH1A1KMT2AMEN1
SCHEMBL2120300 0.67
SCHEMBL13304562 0.67 HSP90AB1 (0.41) PKMHSP90AB1L3MBTL1KDM4EMAPT
SCHEMBL3625881 0.67 HSP90AB1 (0.46) HSP90AB1ALDH1A1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10858367-B2 Compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-12-08 US disclosed
US-10858367-B2 Compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-12-08 US disclosed
CN-110446700-A Compound GLAXOSMITHKLINE IP DEV LTD 2019-11-12 CN disclosed
WO-2018137593-A1 COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-08-02 WO disclosed
US-5726128-A Benzyloxypyrimidine derivative, processes for producing the same and herbicidal composition KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1998-03-10 US disclosed
US-5723412-A HERBICIDES KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1998-03-03 US disclosed
EP-0707001-A1 Benzyloxypyrimidine derivative, processes for producing the same and herbicidal composition KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1996-04-17 EP disclosed
EP-0694538-A2 2-benzyloxy-4-phenoxypyrimidine derivative, processes for producing the derivative and herbicidal composition containing the derivative KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1996-01-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10858367-B2 Compounds LRRK2, PARK7, PINK1 PKM 456/4885HSP90AB1 521/4885ALDH1A1 3758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.